Clinical Development: Rare Disease

whitePaper | November 15, 2022

The COVID-19 pandemic has exposed the vulnerabilities of global and national health systems. Already-struggling healthcare systems have shifted their resources to the pandemic response

whitePaper | November 11, 2021

Care providers and payers are shackled by a myriad of processes and accompanying documents to authorize, deliver, and record healthcare services. From patient health records to care provider information and payment data, the web of processes involved in care delivery and reimbursements quickly breach human interest, resulting in monotonous work for the people involved. Healthcare automation can eliminate the time spent by personnel working on time-intensive, low-value, and rule-based tasks. In this white paper, we explore the nature of Robotic Process Automation (RPA) and the key areas for care providers and payer organizations to focus on to leverage the power of RPA.

whitePaper | March 3, 2023

Hospitals throughout the United States and worldwide have struggled with understaffing for years, with the effects of the COVID-19 pandemic pushing them to their limits.

whitePaper | August 23, 2022

As the market enters the post-pandemic era, payers and providers are tasked with providing a customer and employee experience that keeps pace with that offered by a new wave of digital-native challengers.

whitePaper | February 18, 2023

In a very short time, healthcare in the United States and in many other countries has been transformed out of necessity to respond to the COVID-19 pandemic.

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.